BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leemans W, Janssen H, de Man R. Future prospectives for the management of chronic hepatitis B. World J Gastroenterol 2007; 13(18): 2554-2567 [PMID: 17552002 DOI: 10.3748/wjg.v13.i18.2554] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Cabuang LM, Shaw T, Littlejohn M, Colledge D, Sozzi V, Soppe S, Warner N, Thompson A, Preiss S, Lam N, Walsh R, Lewin SR, Thio CL, Matthews G, Locarnini SA, Revill PA. In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection. J Med Virol 2012;84:1166-76. [PMID: 22711344 DOI: 10.1002/jmv.23328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
2 Wu XJ, Wang Y, Chen J, Wang GQ. Baseline predictors of virological response for chronic hepatitis B patients. World J Gastroenterol 2009;15:4311-5. [PMID: 19750575 DOI: 10.3748/wjg.15.4311] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-Katz EF. Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir. Am J Addict 2010;19:17-29. [PMID: 20132118 DOI: 10.1111/j.1521-0391.2009.00004.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ma L, Song J, Shi Y, Wang C, Chen B, Xie D, Jia X. Anti-hepatitis B virus activity of chickweed [Stellaria media (L.) Vill.] extracts in HepG2.2.15 cells. Molecules 2012;17:8633-46. [PMID: 22810196 DOI: 10.3390/molecules17078633] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Dakin H, Fidler C, Harper C. Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B. Value Health. 2010;13:934-945. [PMID: 20825624 DOI: 10.1111/j.1524-4733.2010.00777.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
6 Alazawi W, Foster GR. Advances in the diagnosis and treatment of hepatitis B. Curr Opin Infect Dis. 2008;21:508-515. [PMID: 18725801 DOI: 10.1097/qco.0b013e32830fb924] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wang C, Hann HW, Hann RS, Wan S, Myers RE, Ye Z, Xing J, Yang H. Circulating mitochondrial DNA content associated with the risk of liver cirrhosis: a nested case-control study. Dig Dis Sci 2015;60:1707-15. [PMID: 25588520 DOI: 10.1007/s10620-015-3523-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Feng M, Cai Q, Shi X, Huang H, Zhou P, Guo X. Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells. J Drug Target 2008;16:502-8. [PMID: 18604663 DOI: 10.1080/10611860802200938] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
9 Lim L, Tran BM, Vincan E, Locarnini S, Warner N. HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA. Future Virology 2012;7:1237-49. [DOI: 10.2217/fvl.12.113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Raoufy MR, Vahdani P, Alavian SM, Fekri S, Eftekhari P, Gharibzadeh S. A Novel Method for Diagnosing Cirrhosis in Patients with Chronic Hepatitis B: Artificial Neural Network Approach. J Med Syst 2011;35:121-6. [DOI: 10.1007/s10916-009-9348-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 von Meltzer M, Vásquez S, Sun J, Wendt UC, May A, Gerlich WH, Radtke M, Schaefer S. A new clade of hepatitis B virus subgenotype F1 from Peru with unusual properties. Virus Genes. 2008;37:225-230. [PMID: 18649130 DOI: 10.1007/s11262-008-0261-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
12 Lepère-Douard C, Trotard M, Le Seyec J, Gripon P. The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol 2009;83:11819-29. [PMID: 19740987 DOI: 10.1128/JVI.01026-09] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
13 Kuakarn S, SomParn P, Tangkijvanich P, Mahachai V, Thongboonkerd V, Hirankarn N. Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b. World J Gastroenterol 2013;19:5067-75. [PMID: 23964140 DOI: 10.3748/wjg.v19.i31.5067] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 Basnayake SK, Easterbrook PJ. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. J Viral Hepat 2016;23:545-59. [PMID: 27028545 DOI: 10.1111/jvh.12519] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
15 Almeida AM, Silva DID, Guerra Jr AA, Silva GD, Acurcio FDA. Revisão sistemática da eficácia do interferon alfa (convencional, peguilado) e lamivudina para o tratamento da hepatite crônica B. Cad Saúde Pública 2009;25:1667-77. [DOI: 10.1590/s0102-311x2009000800003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim M, Choi H, Min JS, Kim YS, Yoon SW. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J Ethnopharmacol. 2009;124:189-196. [PMID: 19409970 DOI: 10.1016/j.jep.2009.04.046] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
17 Song YN, Zhang H, Guan Y, Peng JH, Lu YY, Hu YY, Su SB. Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis. Evid Based Complement Alternat Med 2012;2012:626320. [PMID: 22693531 DOI: 10.1155/2012/626320] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
18 Luxembourg A, Hannaman D, Wills K, Bernard R, Tennant BC, Menne S, Cote PJ. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens. Vaccine 2008;26:4025-33. [PMID: 18556096 DOI: 10.1016/j.vaccine.2008.05.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
19 Feng M, Cai Q, Shi X, Huang H, Zhou P, Guo X. Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells. Journal of Drug Targeting 2008;16:502-8. [DOI: 10.1080/10611860802200938] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Gujral H, Collantes RS. Understanding viral hepatitis: a guide for primary care. Nurse Pract 2009;34:23-31; quiz 31-2. [PMID: 19952584 DOI: 10.1097/01.NPR.0000365124.50786.b5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]